Details for New Drug Application (NDA): 217604
The generic ingredient in PYRIDOSTIGMINE BROMIDE is pyridostigmine bromide. There is one drug master file entry for this compound. Twenty suppliers are listed for this compound. Additional details are available on the pyridostigmine bromide profile page.
Summary for 217604
| Tradename: | PYRIDOSTIGMINE BROMIDE |
| Applicant: | Amneal |
| Ingredient: | pyridostigmine bromide |
| Patents: | 9 |
Pharmacology for NDA: 217604
| Mechanism of Action | Cholinesterase Inhibitors |
Medical Subject Heading (MeSH) Categories for 217604
Suppliers and Packaging for NDA: 217604
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| PYRIDOSTIGMINE BROMIDE | pyridostigmine bromide | TABLET, EXTENDED RELEASE;ORAL | 217604 | NDA | Amneal Pharmaceuticals LLC | 60846-559 | 60846-559-10 | 10 CARTON in 1 BAG (60846-559-10) / 1 BLISTER PACK in 1 CARTON (60846-559-27) / 7 TABLET, EXTENDED RELEASE in 1 BLISTER PACK |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 105MG | ||||
| Approval Date: | Oct 4, 2024 | TE: | RLD: | No | |||||
| Patent: | 10,881,617 | Patent Expiration: | Jun 18, 2038 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
| Patent: | 10,925,833 | Patent Expiration: | Jun 18, 2038 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
| Patent: | 10,987,311 | Patent Expiration: | Jun 18, 2038 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Complete Access Available with Subscription
